Yann Echelard

Track

Insider profile

Currently holds a position at TG Therapeutics Inc

Performance

Overall performance
2.6
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 11% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 130%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director TG Therapeutics Inc Nov. 9, 2012 -
Yann Echelard's trades of TG Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-24
S Sale
23,815 +5.6%
426.45
US$1,974,033 		23,815 +5.6% 426.45 US$1,974,033
2025-11-24 2025-11-24
PrS Proposed sale
58,823
155.41
US$1,638,371 		58,823 155.41 US$1,638,371
2025-06-16 2025-06-13
S Sale
33,403 -36.5%
198.75
US$1,662,423 		33,403 -36.5% 198.75 US$1,662,423
2025-06-13 2025-06-13
PrS Proposed sale
10,000
36.93
US$369,348 		10,000 36.93 US$369,348
2024-11-07 2024-11-05
S Sale
20,000 -8.2%
24.48
US$489,600 		20,000 -8.2% 24.48 US$489,600
2024-11-05 2024-11-05
PrS Proposed sale
20,000
24.48
US$489,500 		20,000 24.48 US$489,500
2023-01-06 2023-01-06
B Purchase
9,000 +4.7%
10.64
US$95,760 		9,000 +4.7% 10.64 US$95,760
2020-12-11 2020-12-10
S Sale
30,000 -18.9%
40.05
US$1,201,500 		30,000 -18.9% 40.05 US$1,201,500